Diagnostic criteria for acute erythroleukemia [2]

Blood

Volumn 101, Issue 7, 2003, Pages 2895-2896

  Selby, Dale M ^a   Valdez, Riccardo ^b   Schnitzer, Bertram ^b   Ross, Charles W ^b   Finn, William G ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW BIOPSY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CELL POPULATION; CYTOGENETICS; ERYTHROBLAST; ERYTHROLEUKEMIA; HUMAN; LETTER; MYELOBLAST; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; CLASSIFICATION; MYELOID LEUKEMIA; NOTE; PATHOLOGY;

HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MYELOID; WORLD HEALTH ORGANIZATION;

EID: 0038107337     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3459     Document Type: Letter

References (6)

1. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292-2302.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
3. Kowal-Vern A, Cotelingham J, Schumacher HR. The prognostic significance of proerythroblasts in acute erythroleukemia. Am J Clin Path. 1992;98:34-40.
4. Mazzella FM, Kowal-Vern A, Shrit MA, Wibowo AL, et al. Acute erythroleukemia evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis. Am J Clin Path. 1998;110:590-598.
5. Foucar K. Bone Marrow Pathology. Chicago, IL: ASCP Press; 2001.
6. McKenna RW, Allison PM. Diagnosis, classification, and course of myelodysplastic syndromes. Clin Lab Med. 1990;10:683-706.